Stora Enso Oyj STERV.HE
Composite 42/100; the shares have moved about 29% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Quality ranks 24/100 — a strong mark against it.
Valuation ranks 70/100 — a moderate point in its favour. Income ranks 66/100 — a moderate point in its favour.
Quality ranks 24/100 — a strong mark against it. Growth ranks 26/100 — a moderate mark against it. Momentum ranks 41/100 — a slight mark against it.
What the company does Stora Enso Oyj produces renewable packaging, biomaterials, wood products, and forest-based solutions across Finland and globally. Its Packaging Materials and Solutions segments replace fossil-based materials with fiber-based alternatives for food, e-commerce, and industrial uses.
Key financials Reported ROE 5.4%, ROA 0.6%, and ROCE 4.8% with net margin 6.2%. Revenue declined -0.1% and EPS fell -71.4%. Debt/Equity is 0.36 and net debt/EBITDA is 4.27, while interest coverage stands at 4.91.
Stock health SideraVia scores Overall 43.3 (“Poor quality, attractively valued”) with Valuation 70.9 and Income 75.0. Piotroski F-Score is 6/9 and Altman Z is 1.77, indicating moderate financial health.
Price vs fair value The stock trades at a PREMIUM of 0.80% versus our fair-value estimate of 9.82 and at a discount of 13.57% versus the 12-month target of 11.24. - Forward P/E 15.13 vs trailing 13.76 signals modest earnings recovery expectations (Valuation). - Gross margin 24.7% supports pricing power in specialty materials (Key financials). - Dividend yield 2.6% and payout 34.7% indicate a balanced return policy (Key financials). - RSI(14) 57.10 points to neutral momentum (Momentum).
Looking forward Analysts project a 12-month target 11.24, implying +13.57% upside from the current price. Forward PEG is not available, and revenue growth remains flat at -0.1%, suggesting limited near-term catalysts.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.